InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

Current share price for RHT : $0.058 0.002 (3.33%)+

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$28 Trading Halt 18 Apr 2006 12:35PM $0.045 $0.058 risen by 28.04%
$28 Canadian Regulatory Clearance by Health Canada for FerriScan 18 Apr 2006 10:11AM $0.045 $0.058 risen by 28.04%
$28 Response to ASX Query re: Share Price 10 Apr 2006 7:17PM $0.060 $0.058 fallen by 2.68%
$28 Granted Second US Patent 20 Mar 2006 11:12AM $0.071 $0.058 fallen by 18.42%
$28 Half Yearly Report 17 Mar 2006 12:57PM $0.072 $0.058 fallen by 19.44%
$28 TGA & CE Full Quality Assurance System Approval 10 Feb 2006 2:10PM $0.089 $0.058 fallen by 34.76%
$28 Quality Management Certification 3 Feb 2006 10:51AM $0.088 $0.058 fallen by 34.09%
$28 Commitments Test Entity - Second Quarter Report 31 Jan 2006 5:06PM $0.089 $0.058 fallen by 34.76%
$28 FerriScan gains independent validation 12 Dec 2005 10:30AM $0.085 $0.058 fallen by 32%
$28 Expands into Fibrosis Field 3 Nov 2005 11:05AM $0.107 $0.058 fallen by 45.64%
$28 Commitments Test Entity - First Quarter Report 31 Oct 2005 6:46PM $0.102 $0.058 fallen by 43.25%
$28 First European Patent Granted 12 Oct 2005 10:27AM $0.107 $0.058 fallen by 45.64%
$28 Awarded WA State Government Health Supply Contract 4 Oct 2005 10:07AM $0.120 $0.058 fallen by 51.67%
$28 $1m Placement & Share Purchase Plan 29 Sep 2005 7:38PM $0.107 $0.058 fallen by 45.64%
$28 Trading Halt 28 Sep 2005 9:34AM n/a $0.058 n/a
$28 Preliminary Final Report 13 Sep 2005 1:30PM $0.120 $0.058 fallen by 51.67%
$28 Signs MOU with major US Radiology Chain 13 Sep 2005 11:10AM $0.116 $0.058 fallen by 49.83%
$28 Agreement with US Research Institute to Supply FerriScan 16 Aug 2005 1:33PM $0.151 $0.058 fallen by 61.61%
$28 To provide expanded FerriScan Serv to pharmaceutical company 5 Aug 2005 11:15AM $0.160 $0.058 fallen by 63.75%
$28 Commitments Test Entity - Fourth Quarter Report 29 Jul 2005 11:54AM $0.142 $0.058 fallen by 59.21%
$28 Placement to Fund Australian Ferriscan 10 Jun 2005 6:57PM $0.116 $0.058 fallen by 49.83%
$28 Cooperate with DCA Group on Commercial Launch of Ferriscan 24 Mar 2005 9:55AM $0.169 $0.058 fallen by 65.66%
$28 Trading Halt 1 Mar 2005 11:13AM $0.196 $0.058 fallen by 70.35%
$28 FDA Approves FerriScan 28 Jan 2005 9:49AM $0.191 $0.058 fallen by 69.65%
$28 US Approval of FerriScan Closer with FDA 510(k) submission 1 Dec 2004 9:54AM $0.142 $0.058 fallen by 59.21%

501 - 525 of 531 results

Page 21 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.